Literature DB >> 25077783

Arthroscopic reduction and acetabuloplasty for the treatment of dislocated hips in children of walking age: a preliminary report.

Oliver Eberhardt1, Thomas Wirth, Francisco Fernandez Fernandez.   

Abstract

INTRODUCTION: This paper presents our initial findings on the use of arthroscopic hip reduction in conjunction with acetabuloplasty to treat patients of walking age who had congenital dislocation of the hip.
MATERIALS AND METHODS: Arthroscopic reduction with acetabuloplasty was performed on nine children of walking age with nine dislocated hips. The average age of the patients was 21.4 months (14-41 months). Arthroscopic reduction was performed using a two-portal method with a 2.7-mm mini cannulated arthroscopic instrument. We used a subadductor portal and a high anterolateral portal. The obstacles preventing reduction-hypertrophic teres ligament, pulvinar, capsular constriction, hypertrophic transverse ligament-were eliminated.
RESULTS: We treated one grade 4 hip, four grade 3 hips and four grade 2 hips, as classified by Tönnis. We were able to perform arthroscopic reduction on all of the hips. The main obstacles preventing reduction were a capsular constriction and a hypertrophic teres ligament. During the investigation period, which averaged 15.4 months (6-29 months), no repeat dislocation occurred. According to the Tönnis classification system for avascular necrosis, there were two cases of a grade 2 necrosis of the femoral head. The average preoperative AC angle was 40° (34°-47°). The average AC angle at the follow-up examination was 18.7° (11°-27°).
CONCLUSIONS: We can conclude that the standardized arthroscopic surgical technique presented here can also be used to safely perform arthroscopic reduction in toddlers. The new arthroscopic method is an alternative to open reduction for selective hip dislocations. We believe this approach can be used to treat dislocated hips that are classified as grades 2 and 3 dislocations according Tönnis. Early results are promising. Medium-term results are needed to make a definitive statement on the rates of necrosis of the femoral head.

Entities:  

Mesh:

Year:  2014        PMID: 25077783     DOI: 10.1007/s00402-014-2063-z

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  7 in total

Review 1.  [Hip dysplasia-new and proven methods].

Authors:  Oliver Eberhardt; T Wirth
Journal:  Orthopade       Date:  2019-06       Impact factor: 1.087

Review 2.  The use of hip arthroscopy in the management of the pediatric hip.

Authors:  Dennis R Roy
Journal:  J Hip Preserv Surg       Date:  2015-12-10

3.  Medium-term results following arthroscopic reduction in walking-age children with developmental hip dysplasia after failed closed reduction.

Authors:  Liang Zhao; Hua Yan; Changsheng Yang; Daozhang Cai; Yijun Wang
Journal:  J Orthop Surg Res       Date:  2017-09-21       Impact factor: 2.359

4.  Effects of arthroscopic-assisted surgery on irreducible developmental dislocation of hip by mid-term follow-up: An observational study.

Authors:  Hui-Fa Xu; Ya-Bo Yan; Chao Xu; Tian-Qing Li; Tian-Feng Zhao; Ning Liu; Lu-Yu Huang; Chun-Li Zhang; Wei Lei
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Arthroscopic versus open, medial approach, surgical reduction for developmental dysplasia of the hip in patients under 18 months of age.

Authors:  Serda Duman; Yalkin Camurcu; Hakan Sofu; Hanifi Ucpunar; Deniz Akbulut; Timur Yildirim
Journal:  Acta Orthop       Date:  2019-04-02       Impact factor: 3.717

6.  Comparison of arthroscopic and open reduction of conservatively irreducible dislocated hips of children.

Authors:  C Presch; O Eberhardt; T Wirth; F F Fernandez
Journal:  J Child Orthop       Date:  2019-08-01       Impact factor: 1.548

7.  A Single Approach to Arthroscopic Reduction and Debridement for Developmental Dislocation of the Hip in 12 Infants.

Authors:  Chao Feng; Xue-Min Lv; Shi-Qi Wan; Yuan Guo
Journal:  Med Sci Monit       Date:  2019-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.